Mark Lackner, Chief Scientific Officer: Zentalis Pharmaceuticals ZNTL Sell · Filed 24/02/05

Trade details

Type: Insider sale
Amount: $18,290.9
Shares · price: 1,585 sh · $11.54 a share
Held after: 195,728 sh
Stock: Zentalis Pharmaceuticals ZNTL
Person: Mark LacknerChief Scientific Officer
Trade date: 24/02/02
Filed: 24/02/05
Days to filing: 3 days

Sold 0.8% of holdings

Share of holding sold: 0.8%

Zentalis Pharmaceuticals trades, last 26 weeks

What else happened in Zentalis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/03~24/03/03

Mark Lackner's recent trades

Mark LacknerChief Scientific Officer
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$24.6K
14,368 sh
$24.6K
Filed 25/02/05
Traded 25/02/03
Lackner MarkChief Scientific Officer
Planned saleZentalis Pharmaceuticals
Planned sale
Zentalis Pharmaceuticals
ZNTL
$24.6K
14,368 sh
$24.6K
Filed 25/02/03
Traded 25/02/03
Mark LacknerChief Scientific Officer
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$13.8K
4,411 sh
$13.8K
Filed 25/01/03
Traded 25/01/02

Mark Lackner, Chief Officer — sold $18.3K of Zentalis Pharmaceuticals ZNTL · 0.8% of holdings | Whalegun